Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
54.8M
-
Number of holders
-
119
-
Total 13F shares, excl. options
-
13.7M
-
Shares change
-
-1.89M
-
Total reported value, excl. options
-
$167M
-
Value change
-
-$24.1M
-
Put/Call ratio
-
1.76
-
Number of buys
-
45
-
Number of sells
-
-56
-
Price
-
$12.24
Significant Holders of Cara Therapeutics, Inc. - Common Stock, par value $0.001 per share (CARA) as of Q4 2017
154 filings reported holding CARA - Cara Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q4 2017.
Cara Therapeutics, Inc. - Common Stock, par value $0.001 per share (CARA) has 119 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13.7M shares
of 54.8M outstanding shares and own 24.93% of the company stock.
Largest 10 shareholders include BlackRock Inc. (2.21M shares), STATE STREET CORP (1.98M shares), Vanguard Group Inc (1.22M shares), Chescapmanager LLC (1.03M shares), FMR LLC (876K shares), DISCIPLINED GROWTH INVESTORS INC /MN (861K shares), PRICE T ROWE ASSOCIATES INC /MD/ (479K shares), FRANKLIN RESOURCES INC (451K shares), JPMORGAN CHASE & CO (355K shares), and SUSQUEHANNA INTERNATIONAL GROUP, LLP (323K shares).
This table shows the top 119 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.